During the past decade, KaRa MINDS conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KaRa MINDS" #1 sponsor was "Anavex Life Sciences Corp." with 3 trials, followed by "Athira Pharma" with 2 trials sponsored, "AZTherapies, Inc." with 1 trials sponsored, "Actinogen Medical" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KaRa MINDS" #1 collaborator was "Anavex Australia Pty Ltd." with 3 trials as a collaborator, "Anavex Germany GmbH" with 3 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Anavex Canada Ltd." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "KaRa MINDS" are "Alzheimer Disease" (8 trials), "Alzheimer's Disease" (2 trials), "Alzheimers Disease" (1 trials), "Dementia of Alzheimer Type" (1 trials) and "Dementia, Alzheimer Type" (1 trials). Many other conditions were trialed in "KaRa MINDS" in a lesser frequency.

Most popular intervention types in "KaRa MINDS" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ANAVEX2-73" (2 trials), "ATH-1017" (2 trials), "ALZT-OP1a" (1 trials) and "ALZT-OP1b" (1 trials). Other intervention names were less common.

The vast majority of trials in "KaRa MINDS" are 15 trials for "All" genders.

Currently, there are NaN active trials in "KaRa MINDS". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in KaRa MINDS, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in KaRa MINDS, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".